4N1K is a synthetic peptide that serves as an antagonist to αvβ3 integrin, blocking cell adhesion and migration. The peptide sequence specifically interacts with integrin receptors to inhibit their signaling pathways. Researchers use it in cancer research to study the role of integrins in tumor metastasis and cell signaling. Its properties make it a powerful tool for studying cell-matrix interactions and integrin-related diseases.
CAT No: C15007
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.